SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-22-006930
Filing Date
2022-02-11
Accepted
2022-02-11 14:54:43
Documents
2
Group Members
ANASTASIOS NIKOLAOUANDREAS HADJIMICHAELMARCIN CZERNIKWIACZESLAW SMOLOKOWSKI

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 7 TO SCHEDULE 13G ea155416-13ga7chione_karyo.htm SC 13G/A 181610
2 JOINT FILING AGREEMENT, DATED FEBRUARY 11, 2021, AMONG THE REPORTING PERSONS ea155416ex99-1_karyo.htm EX-99.1 5085
  Complete submission text file 0001213900-22-006930.txt   188346
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Subject) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87705 | Film No.: 22619819
SIC: 2834 Pharmaceutical Preparations

Mailing Address SIMOU MENARDOU 8, RIA COURT 8 OFFICE 101, 6015 LARNACA G4 CY
Business Address SIMOU MENARDOU 8, RIA COURT 8 OFFICE 101, 6015 LARNACA G4 CY 48 (22) 840 8342
Chione Ltd (Filed by) CIK: 0001590232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G4
Type: SC 13G/A